110 related articles for article (PubMed ID: 22057094)
1. The human relevant potency threshold: reducing uncertainty by human calibration of cumulative risk assessments.
Borgert CJ; Sargent EV; Casella G; Dietrich DR; McCarty LS; Golden RJ
Regul Toxicol Pharmacol; 2012 Mar; 62(2):313-28. PubMed ID: 22057094
[TBL] [Abstract][Full Text] [Related]
2. Combined exposures to anti-androgenic chemicals: steps towards cumulative risk assessment.
Kortenkamp A; Faust M
Int J Androl; 2010 Apr; 33(2):463-74. PubMed ID: 20487045
[TBL] [Abstract][Full Text] [Related]
3. Reducing uncertainty of risk estimates for mixtures of chemicals within regulatory constraints.
Putzrath RM
Regul Toxicol Pharmacol; 2000 Feb; 31(1):44-52. PubMed ID: 10715223
[TBL] [Abstract][Full Text] [Related]
4. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
[TBL] [Abstract][Full Text] [Related]
5. Toxicology and carcinogenesis studies of a binary mixture of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) and 2,3',4,4',5-pentachlorobiphenyl (PCB 118) (Cas No. 31508-00-6) in female Harlan Sprague-Dawley rats (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Nov; (531):1-218. PubMed ID: 17342196
[TBL] [Abstract][Full Text] [Related]
6. Reducing uncertainty in risk assessment by using specific knowledge to replace default options.
McClellan RO
Drug Metab Rev; 1996; 28(1-2):149-79. PubMed ID: 8744594
[TBL] [Abstract][Full Text] [Related]
7. Assessing the risks of exposures to multiple chemicals with a common mechanism of toxicity: how to cumulate?
Wilkinson CF; Christoph GR; Julien E; Kelley JM; Kronenberg J; McCarthy J; Reiss R
Regul Toxicol Pharmacol; 2000 Feb; 31(1):30-43. PubMed ID: 10715222
[TBL] [Abstract][Full Text] [Related]
8. Addressing nonlinearity in the exposure-response relationship for a genotoxic carcinogen: cancer potency estimates for ethylene oxide.
Kirman CR; Sweeney LM; Teta MJ; Sielken RL; Valdez-Flores C; Albertini RJ; Gargas ML
Risk Anal; 2004 Oct; 24(5):1165-83. PubMed ID: 15563286
[TBL] [Abstract][Full Text] [Related]
9. Development of a neurotoxic equivalence scheme of relative potency for assessing the risk of PCB mixtures.
Simon T; Britt JK; James RC
Regul Toxicol Pharmacol; 2007 Jul; 48(2):148-70. PubMed ID: 17475378
[TBL] [Abstract][Full Text] [Related]
10. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
11. Risk management frameworks for human health and environmental risks.
Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
[TBL] [Abstract][Full Text] [Related]
12. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.
Müller L; Gocke E; Lavé T; Pfister T
Toxicol Lett; 2009 Nov; 190(3):317-29. PubMed ID: 19443141
[TBL] [Abstract][Full Text] [Related]
13. Chloroform mode of action: implications for cancer risk assessment.
Golden RJ; Holm SE; Robinson DE; Julkunen PH; Reese EA
Regul Toxicol Pharmacol; 1997 Oct; 26(2):142-55. PubMed ID: 9356278
[TBL] [Abstract][Full Text] [Related]
14. Precision of estimates of an ADI (or TDI or PTWI).
Speijers GJ
Regul Toxicol Pharmacol; 1999 Oct; 30(2 Pt 2):S87-93. PubMed ID: 10597619
[TBL] [Abstract][Full Text] [Related]
15. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
Gaylor DW
Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
[TBL] [Abstract][Full Text] [Related]
16. Toxicology and carcinogenesis studies of a mixture of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Cas No. 1746-01-6), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4), and 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) in female Harlan Sprague-Dawley rats (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Sep; (526):1-180. PubMed ID: 17342195
[TBL] [Abstract][Full Text] [Related]
17. Using dose addition to estimate cumulative risks from exposures to multiple chemicals.
Chen JJ; Chen YJ; Rice G; Teuschler LK; Hamernik K; Protzel A; Kodell RL
Regul Toxicol Pharmacol; 2001 Aug; 34(1):35-41. PubMed ID: 11502154
[TBL] [Abstract][Full Text] [Related]
18. An integrated probabilistic framework for cumulative risk assessment of common mechanism chemicals in food: an example with organophosphorus pesticides.
Bosgra S; van der Voet H; Boon PE; Slob W
Regul Toxicol Pharmacol; 2009 Jul; 54(2):124-33. PubMed ID: 19303907
[TBL] [Abstract][Full Text] [Related]
19. Can mode of action predict mixture toxicity for risk assessment?
Borgert CJ; Quill TF; McCarty LS; Mason AM
Toxicol Appl Pharmacol; 2004 Dec; 201(2):85-96. PubMed ID: 15541748
[TBL] [Abstract][Full Text] [Related]
20. Acrylamide: review of toxicity data and dose-response analyses for cancer and noncancer effects.
Shipp A; Lawrence G; Gentry R; McDonald T; Bartow H; Bounds J; Macdonald N; Clewell H; Allen B; Van Landingham C
Crit Rev Toxicol; 2006; 36(6-7):481-608. PubMed ID: 16973444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
